(Q41379235)

30 September 2017

title

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex (English)

1 reference

30 September 2017

0 references

1 reference

Gallo RC

1 reference

30 September 2017

Marjorie Robert-Guroff

series ordinal

object named as

Robert-Guroff M

1 reference

30 September 2017

Brown M

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 July 1985

1 reference

30 September 2017

1 reference

30 September 2017

volume

316

1 reference

30 September 2017

issue

6023

1 reference

30 September 2017

page(s)

72-74

1 reference

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

30 September 2017

cites work

1 reference

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

7 January 2021

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1 reference

7 January 2021

Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

1 reference

7 January 2021

Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men

1 reference

7 January 2021

Association of HTLV-III Antibodies and Cellular Immune Status of Hemophiliacs

1 reference

7 January 2021

Antibodies to HTLV-III in Haitian Immigrants in French Guiana

1 reference

7 January 2021

Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS.

1 reference

7 January 2021

Acquired immunodeficiency syndrome in African patients.

1 reference

7 January 2021

Evidence for exposure to HTLV-III in Uganda before 1973

1 reference

7 January 2021

Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera

1 reference

7 January 2021

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

7 January 2021

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

1 reference

7 January 2021

Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein

1 reference

7 January 2021

Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity

1 reference

7 January 2021

Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus

1 reference

7 January 2021

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1 reference

7 January 2021

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

1 reference

7 January 2021

Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody

1 reference

7 January 2021

Identifiers

DOI

10.1038/316072A0

1 reference

Dimensions Publication ID

30 September 2017

1043416435

0 references

1 reference